Literature DB >> 8423803

Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1.

J T Cheng1, M H Cobb, R Baer.   

Abstract

Alteration of the TAL1 gene is the most common genetic lesion found in T-cell acute lymphoblastic leukemia. TAL1 encodes phosphoproteins, pp42TAL1 and pp22TAL1, that represent phosphorylated versions of the full-length (residues 1 to 331) and truncated (residues 176 to 331) TAL1 gene products, respectively. Both proteins contain the basic helix-loop-helix motif, a DNA-binding and protein dimerization motif common to several known transcriptional regulatory factors. We now report that serine residue 122 (S122) is a major phosphorylation site of pp42TAL1 in leukemic cell lines and transfected COS1 cells. In vivo phosphorylation of S122 is induced by epidermal growth factor with a rapid time course that parallels activation of the ERK/MAP2 protein kinases. Moreover, S122 is readily phosphorylated in vitro by the extracellular signal-regulated protein kinase ERK1. These data suggest that TAL1 residue S122 serves as an in vivo substrate for ERK/MAP2 kinases such as ERK1. Therefore, S122 phosphorylation may provide a mechanism whereby the properties of TAL1 polypeptides can be modulated by extracellular stimuli.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423803      PMCID: PMC358963          DOI: 10.1128/mcb.13.2.801-808.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Sequence of pp42/MAP kinase, a serine/threonine kinase regulated by tyrosine phosphorylation.

Authors:  J H Her; J Wu; T B Rall; T W Sturgill; M J Weber
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

Review 2.  Recent progress in characterization of protein kinase cascades for phosphorylation of ribosomal protein S6.

Authors:  T W Sturgill; J Wu
Journal:  Biochim Biophys Acta       Date:  1991-05-17

3.  Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates.

Authors:  W J Boyle; P van der Geer; T Hunter
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 4.  Translocations, master genes, and differences between the origins of acute and chronic leukemias.

Authors:  T H Rabbitts
Journal:  Cell       Date:  1991-11-15       Impact factor: 41.582

5.  Purification and properties of extracellular signal-regulated kinase 1, an insulin-stimulated microtubule-associated protein 2 kinase.

Authors:  T G Boulton; J S Gregory; M H Cobb
Journal:  Biochemistry       Date:  1991-01-08       Impact factor: 3.162

6.  Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene.

Authors:  O Bernard; N Lecointe; P Jonveaux; M Souyri; M Mauchauffé; R Berger; C J Larsen; D Mathieu-Mahul
Journal:  Oncogene       Date:  1991-08       Impact factor: 9.867

7.  Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase.

Authors:  E Alvarez; I C Northwood; F A Gonzalez; D A Latour; A Seth; C Abate; T Curran; R J Davis
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

8.  Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.

Authors:  K L Guan; J E Dixon
Journal:  Anal Biochem       Date:  1991-02-01       Impact factor: 3.365

9.  Phosphorylation of c-jun mediated by MAP kinases.

Authors:  B J Pulverer; J M Kyriakis; J Avruch; E Nikolakaki; J R Woodgett
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

10.  A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression.

Authors:  A Seth; E Alvarez; S Gupta; R J Davis
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

View more
  24 in total

1.  Basal extracellular signal-regulated kinase activity modulates cell-cell and cell-matrix interactions.

Authors:  Q Lu; M Paredes; J Zhang; K S Kosik
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

2.  The pool of map kinase associated with microtubules is small but constitutively active.

Authors:  M Morishima-Kawashima; K S Kosik
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

3.  The SCL gene specifies haemangioblast development from early mesoderm.

Authors:  M Gering; A R Rodaway; B Göttgens; R K Patient; A R Green
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

Review 4.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

5.  A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1.

Authors:  Z Songyang; K P Lu; Y T Kwon; L H Tsai; O Filhol; C Cochet; D A Brickey; T R Soderling; C Bartleson; D J Graves; A J DeMaggio; M F Hoekstra; J Blenis; T Hunter; L C Cantley
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

6.  Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression.

Authors:  S J Kim; C R Kahn
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

7.  RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis.

Authors:  Ande Satyanarayana; Kristbjorn Orri Gudmundsson; Xiu Chen; Vincenzo Coppola; Lino Tessarollo; Jonathan R Keller; Steven X Hou
Journal:  Blood       Date:  2010-07-01       Impact factor: 22.113

Review 8.  Networking with mitogen-activated protein kinases.

Authors:  S L Pelech; D L Charest; G P Mordret; Y L Siow; C Palaty; D Campbell; L Charlton; M Samiei; J S Sanghera
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

Review 9.  Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.

Authors:  N C Correia; M-L Arcangeli; F Pflumio; J T Barata
Journal:  Leukemia       Date:  2016-06-13       Impact factor: 11.528

10.  The SCL gene product is regulated by and differentially regulates cytokine responses during myeloid leukemic cell differentiation.

Authors:  T Tanigawa; N Elwood; D Metcalf; D Cary; E DeLuca; N A Nicola; C G Begley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.